ideology-health
  • Our Solutions
  • About Us
  • Dr. Martin Dietrich reviews the evidence trastuzumab deruxtecan (T-Dxd) in gastric cancer (Video 2/3)
    Sign up to watch this video

    Free access to all Sound Bites content

    Dr. Martin Dietrich reviews the evidence trastuzumab deruxtecan (T-Dxd) in gastric cancer (Video 2/3)

    Published 1 day ago


    M

    Martin Dietrich

    Medical Professional


    T-Dxd in Gastric

    Related Videos
    Dr. Martin Dietrich reviews the evidence trastuzumab deruxtecan (T-Dxd) in gastric cancer (Video 2/3)

    Dr. Martin Dietrich reviews the evidence trastuzumab deruxtecan (T-Dxd) in gastric cancer (Video 2/3)

    Martin Dietrich
    Dr. Edgardo Santos discusses the emergence of SQ amivantamab+lazertinib in 1L EGFRm mNSCLC (Video 1/3)

    Dr. Edgardo Santos discusses the emergence of SQ amivantamab+lazertinib in 1L EGFRm mNSCLC (Video 1/3)

    Edgardo Santos, MD
    Dr. Manali Kamdar discusses the curative potential of 2L CAR-T with liso-cel in R/R LBCL  (Video 1/3)

    Dr. Manali Kamdar discusses the curative potential of 2L CAR-T with liso-cel in R/R LBCL (Video 1/3)

    Manali Kamdar, MD
    Dr. Joshua Reuss reviews additional efficacy endpoints in treatment naïve population from the BEAMION trial of zongertinib in HER2m NSCLC (Video 2/3)

    Dr. Joshua Reuss reviews additional efficacy endpoints in treatment naïve population from the BEAMION trial of zongertinib in HER2m NSCLC (Video 2/3)

    Joshua Reuss, MD
    Dr. Himisha Beltran discusses a paradigm shift for BRCA2 mutations in prostate cancer (Video 1/3)

    Dr. Himisha Beltran discusses a paradigm shift for BRCA2 mutations in prostate cancer (Video 1/3)

    Himisha Beltran, MD
    Dr. Amer Zeidan discusses insights on anemia in lower-risk MDS and the use of luspatercept (Video 1/3)

    Dr. Amer Zeidan discusses insights on anemia in lower-risk MDS and the use of luspatercept (Video 1/3)

    Amer Zeidan, MD
    ideology-health
    Privacy Policy
    Terms of Service
    Inc. 5000

    IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America

    © 2025 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.